Withdraw due to duplicate registration. Registry of Pre-mixed Solutions in Critically ill Patients on the Continuous Renal Replacement Therapy (PrioR)

Registry of Pre-mixed Solutions in Critically ill Patients on the Continuous Renal Replacement Therapy (PrioR): a multicenter, prospective real-world study

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2500096865

Enrollment

Unknown

Registered

2025-02-07

Start date

2024-10-23

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

critically ill adult patients who require CRRT

Interventions

Case series:NA

Eligibility

Sex/Gender

All

Age

18 Years to 79 Years

Inclusion criteria

Inclusion criteria: 1. 18 <= age < 80 years old. 2. Patients admitted to the ICU and in need of CRRT. 3. Patients are willing to receive CRRT with at least one of three pre-mixed solutions: Regiocit, Biphozyl, or Prismasol 2.

Exclusion criteria

Exclusion criteria: 1. Patients with chronic kidney failure who are receiving maintenance dialysis. 2. Patients expected to require the premixed solution for less than 24 hours. 3. Patients who are allergic or have contraindications to components of pre-mixed solutions, as determined by the investigators. 4. Patients who have participated in other interventional studies within the last 30 days. 5. Patients who are pregnant, breastfeeding, or abortus imminence.

Design outcomes

Secondary

Measure	Time frame
User experience of the pre-mixed solutions;Collection of Electrolyte and Acid-Base indicators;Severe bleeding events;Citrate accumulation;AEs / SAEs;Filter lifespan;	—

Countries

China

Contacts

Public ContactWenxiong Li

Beijing Chao-Yang Hospital, Capital Medical University

lwx7115@sina.com+86 10 85231777

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026